Expression of sialidase and dystroglycan in human glomerular diseases

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 478-484

  Vogtländer, Nils P J ^a   Van Der Vlag, Johan ^a   Bakker, Marinka A H ^a   Dijkman, Henry B ^b   Wevers, Ron A ^c   Campbell, Kevin P ^d   Wetzels, Jack F M ^a   Berden, Jo H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Pathology ^*

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Dystroglycan; Podocalyxin; Podocyte; Sialic acid; Sialidase

Indexed keywords

DYSTROGLYCAN; SIALIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LIQUID CHROMATOGRAPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGED; DYSTROGLYCANS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; NEURAMINIDASE; YOUNG ADULT;

EID: 75649135886     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp465     Document Type: Article

References (42)

1. Feehally J, Floege J, Johnson RJ. Comprehensive Clinical Nephrology. 3rd edn. Philadelphia: Mosby Elsevier, 2007
2. Van Den Born J, Van Den Heuvel LP, Bakker MA et al. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 1993; 43: 454-463
3. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88: 451-487
4. Raats CJ, Van Den Born J, Berden JH. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int 2000; 57: 385-400
5. Kanwar YS, Farquhar MG. Detachment of endothelium and epithelium from the glomerular basement membrane produced by kidney perfusion with neuraminidase. Lab Invest 1980; 42: 375-384
6. Gelberg H, Healy L, Whiteley H et al. In vivo enzymatic removal of alpha 2→6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab Invest 1996; 74: 907-920
7. Miner JH. Glomerular filtration: the charge debate charges ahead. Kidney Int 2008; 74: 259-261
8. Morita H, Yoshimura A, Kimata K. The role of heparan sulfate in the glomerular basement membrane. Kidney Int 2008; 73: 247-248
9. Harvey SJ, Jarad G, Cunningham J et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 2007; 171: 139-152
10. Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y et al. Loss of hep-aran sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 2008; 74: 289-299
11. Van Den Hoven MJ, Wijnhoven TJ, Li JP et al. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int 2008; 73: 278-287
12. Singh A, Satchell SC, Neal CR et al. Glomerular endothelial glyco-calyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18: 2885-2893
13. Vogtlander NPJ, Dijkman H, Bakker MAH et al. Localization of alpha-dystroglycan on the podocyte: from top to toe. J Histochem Cytochem 2005; 53: 1345-1353
14. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T et al. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993; 2: 1651-1657
15. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992; 355: 696-702
16. Raats CJ, Van Den Born J, Bakker MA et al. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 2000; 156: 1749-1765
17. Vogtlander NPJ, Tamboer WPM, Bakker MAH et al. Reactive oxygen species deglycosilate glomerular alpha-dystroglycan.Kidney Int 2006; 69: 1526-1534
18. Vogtlander NPJ, Visch HJ, Bakker MA et al. Ligation of alpha-dystroglycan on podocytes induces intracellular signaling. A new mechanism for podocyte effacement? PLoS ONE 2009; 4: e5979
19. Orlando RA, Takeda T, Zak B et al. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 2001; 12: 1589-1598
20. Lai KW, Wei CL, Tan LK et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 2007; 18: 1476-1485
21. Regele HM, Fillipovic E, Langer B et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000; 11: 403-412
22. Luimula P, Sandstrom N, Novikov D et al. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002; 82: 713-718
23. Andrews PM. Glomerular epithelial alterations resulting from sialic acid surface coat removal. Kidney Int 1979; 15: 376-385
24. Galeano B, Klootwijk R, Manoli I et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.J Clin Invest 2007; 117: 1585-1594
25. Quaggin SE. Sizing up sialic acid in glomerular disease. J Clin Invest 2007; 117: 1480-1483
26. Skutelsky E, Hartzan S, Socher R et al. Modifications in glomerular polyanion distribution in adriamycin nephrosis. J Am Soc Nephrol 1995; 5: 1799-1805
27. Cohen-Forterre L, Mozere G, Andre J et al. Studiesonkidney sialidase in normal and diabetic rats.Biochim Biophys Acta 1984; 801: 138-145
28. Cardenas A, Schadeck C, Bernard A et al. Depletion of sialic acid without changes in sialidase activity in glomeruli of uninephrec-tomized diabetic rats. Biochem Med Metab Biol 1991; 46: 416-421
29. Baricos WH, Cortez-Schwartz S, Shah SV. Renal neuraminidase. Characterization in normal rat kidney and measurement in experimentally induced nephrotic syndrome. Biochem J 1986; 239: 705-710
30. Deegens JK, Assmann KJ, Steenbergen EJ et al. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? Neth J Med 2005; 63: 393-398
31. Branten AJ, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 2005; 16: 169-174
32. Raats CJ, Bakker MA, HochWet al.Differential expressionofagrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 1998; 273: 17832-17838
33. Grootscholten C, Bajema IM, Florquin S et al. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant 2008; 23: 223-230
34. Deegens JK, Steenbergen EJ, Wetzels JF. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med 2008; 66: 3-12
35. Holthofer H, Virtanen I. Glycosylation of developing human glomeruli: lectin binding sites during cell induction and maturation. J Histochem Cytochem 1987; 35: 33-37
36. Faraggiana T, Malchiodi F, Prado A et al. Lectin-peroxidase conjugate reactivity in normal human kidney. J Histochem Cytochem 1982; 30: 451-458
37. Rogerieux F, Belaise M, Terzidis-Trabelsi H et al. Determination of the sialic acid linkage specificity of sialidases using lectins in a solid phase assay. Anal Biochem 1993; 211: 200-204
38. Cohen-Forterre L, Mozere G, Andre J et al. Cleavage of oligosaccha-rides by rat kidney sialidase. Influence of substrate structure. FEBS Lett 1984; 173: 191-195
39. Vinogradova MV, Michaud L, Mezentsev AV et al. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. Biochem J 1998; 330(Pt 2): 641-650
40. Hinek A, Pshezhetsky AV, von Itzstein M et al. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem 2006; 281: 3698-3710
41. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966
42. Harvey SJ, Miner JH. Revisiting the glomerular charge barrier in the molecular era. Curr Opin Nephrol Hypertens 2008; 17: 393-398